BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 20843825)

  • 1. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
    Schmid-Kubista KE; Tosakulwong N; Wu Y; Ryu E; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5070-9. PubMed ID: 19553609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2008 Apr; 17(7):971-7. PubMed ID: 18084039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.
    Hughes AE; Orr N; Esfandiary H; Diaz-Torres M; Goodship T; Chakravarthy U
    Nat Genet; 2006 Oct; 38(10):1173-7. PubMed ID: 16998489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
    Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
    Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
    Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.
    Martínez-Barricarte R; Recalde S; Fernández-Robredo P; Millán I; Olavarrieta L; Viñuela A; Pérez-Pérez J; García-Layana A; Rodríguez de Córdoba S;
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1087-94. PubMed ID: 22247456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
    Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
    Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.
    Liu X; Zhao P; Tang S; Lu F; Hu J; Lei C; Yang X; Lin Y; Ma S; Yang J; Zhang D; Shi Y; Li T; Chen Y; Fan Y; Yang Z
    Retina; 2010 Sep; 30(8):1177-84. PubMed ID: 20523265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
    Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
    Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.
    Raychaudhuri S; Ripke S; Li M; Neale BM; Fagerness J; Reynolds R; Sobrin L; Swaroop A; Abecasis G; Seddon JM; Daly MJ
    Nat Genet; 2010 Jul; 42(7):553-5; author reply 555-6. PubMed ID: 20581873
    [No Abstract]   [Full Text] [Related]  

  • 13. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.
    Alic L; Papac-Milicevic N; Czamara D; Rudnick RB; Ozsvar-Kozma M; Hartmann A; Gurbisz M; Hoermann G; Haslinger-Hutter S; Zipfel PF; Skerka C; Binder EB; Binder CJ
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9942-9951. PubMed ID: 32321835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
    Zhu L; Zhai YL; Wang FM; Hou P; Lv JC; Xu DM; Shi SF; Liu LJ; Yu F; Zhao MH; Novak J; Gharavi AG; Zhang H
    J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes.
    Thompson CL; Klein BE; Klein R; Xu Z; Capriotti J; Joshi T; Leontiev D; Lee KE; Elston RC; Iyengar SK
    Hum Mol Genet; 2007 Sep; 16(17):2135-48. PubMed ID: 17591627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration and coronary heart disease: evaluation of genetic and environmental associations.
    Keilhauer CN; Fritsche LG; Guthoff R; Haubitz I; Weber BH
    Eur J Med Genet; 2013 Feb; 56(2):72-9. PubMed ID: 23103884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
    PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of CFH polymorphisms and CFHR1-CFHR3 deletion with blood pressure and hypertension in Chinese population.
    Gan W; Wu J; Lu L; Xiao X; Huang H; Wang F; Zhu J; Sun L; Liu G; Pan Y; Li H; Lin X; Chen Y
    PLoS One; 2012; 7(7):e42010. PubMed ID: 22848687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.